IPD NMA results: EQ-5D preference scores endpointa | Model 2, ANCOVA, with adjustment for baseline score, age and treatment-by-age interactions, median MCMC posterior sample (95Â % CrI) | ||
---|---|---|---|
Relative treatment effects | Osteoarthritis of the knee | SHAM vs UC | 0.040 (-0.006, 0.084) |
ACU vs UC | 0.066 (0.025, 0.105) | ||
ACU vs SHAM | 0.026 (-0.012, 0.066) | ||
Headache | SHAM vs UC | 0.056 (0.012, 0.098) | |
ACU vs UC | 0.060 (0.023, 0.095) | ||
ACU vs SHAM | 0.004 (-0.036, 0.043) | ||
Musculoskeletal | SHAM vs UC | 0.045 (-0.001, 0.094) | |
ACU vs UC | 0.074 (0.038, 0.109) | ||
ACU vs SHAM | 0.029 (-0.009, 0.067) | ||
Main effects | Age | -0.002 (-0.002, -0.001) | |
Age 2 | 0.000 (0.000, 0.000) | ||
Age common interactions | Age | 0.000 (0.000, 0.001) | |
Age 2 | 0.000 (0.000, 0.000) | ||
 | Between-study variance | 0.001 (0.000,0.003) | |
Total residual deviance b | 15,590 (15,210; 15,970) | ||
Deviance information criterion c | -6,462.0 |